cannabis indica

Índice completo — página 70 de 77

Estudos 6.901 a 7.000 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2007 a 2006. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.901 a 7.000

  1. 2007

    Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

  2. 2007

    Dronabinol and retinal hemodynamics in humans.

    FavorávelEnsaio ClínicoGlaucomaTetraidrocanabinol (THC)THC Farmacêutico
  3. 2007

    Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  4. 2007

    Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward.

    FavorávelEstudo em AnimaisLibidoDisfunção ErétilAnandamida (AEA)
  5. 2007

    Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models

  6. 2007

    Endocannabinoids And Traumatic Brain Injury

  7. 2007

    Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoides Sintéticos HU-x
  8. 2007

    Exposure to terrorism and Israeli youths' cigarette, alcohol, and cannabis use

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+2
  9. 2007

    Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus

    FavorávelEstudo LaboratorialDiabetesSíndrome MetabólicaÁcido Pentadecanoico (C15:0)
  10. 2007

    High-cholesterol feeding aggravates cerebral infarction via decreasing the CB1 receptor

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica+2
  11. 2007

    HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor

  12. 2007

    Identification of GPR55 as a lysophosphatidylinositol receptor

    FavorávelEstudo LaboratorialEndocanabinoide (não especificado)Lisofosfatidilinositol (LPI)
  13. 2007

    Inhibition of human hair follicle growth by endo- and exocannabinoids.

    FavorávelEstudo LaboratorialQueda de CabeloCrescimento Anormal de PelosAnandamida (AEA)
  14. 2007

    Inhibitory effect of b-pinene, a-pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria

    FavorávelEstudo LaboratorialInfecções Bacterianas
  15. 2007

    Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  16. 2007

    Interactions Between Endocannabinoids and Stress-Induced Decreased Sensitivity to Natural Reward

  17. 2007

    Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

    FavorávelEstudo em AnimaisDorDor — CrônicaDII — Doença Inflamatória IntestinalMicrobioma+1
  18. 2007

    Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.

    FavorávelEstudo em AnimaisDepressãoCanabinoides Sintéticos AM-xCanabinoides Sintéticos HU-x+1
  19. 2007

    Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?

  20. 2007

    Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature

    FavorávelMetanáliseEpilepsiaParalisia Cerebral
  21. 2007

    MDMA attenuates THC withdrawal syndrome in mice

  22. 2007

    Modulation of Airway Responses to Influenza A/PR/8/34 by 9-Tetrahydrocannabinol in C57BL/6 Mice

    DesfavorávelEstudo em AnimaisGripeTetraidrocanabinol (THC)
  23. 2007

    N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors

    InconclusivoEstudo LaboratorialN-Araquidonoil Dopamina (NADA)
  24. 2007

    Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies

  25. 2007

    Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity.

  26. 2007

    Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — Opioides
  27. 2007

    Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

  28. 2007

    Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats

    DesfavorávelEstudo em AnimaisAlterações Cerebrais Neonatais
  29. 2007

    Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity

  30. 2007

    Potentiating Effect Of Beta-caryophyllene On Anticancer Activity Of Alpha-humulene, Isocaryophyllene And Paclitaxel

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  31. 2007

    Prevalence of alcohol and illicit drugs in blood specimens from drivers involved in traffic law offenses. Systematic review of cross-sectional studies

    DesfavorávelMetanálise ClínicaTetraidrocanabinol (THC)
  32. 2007

    Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTetraidrocanabinol (THC)
  33. 2007

    Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew

  34. 2007

    Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids

    InconclusivoEstudo LaboratorialAnandamida (AEA)N-Araquidonoil Dopamina (NADA)
  35. 2007

    Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients

    FavorávelMetanálise ClínicaObesidadeDiabetesCanabinoide Sintético (não especificado)
  36. 2007

    Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol

  37. 2007

    Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study

    FavorávelEnsaio ClínicoDorAnandamida (AEA)Palmitoiletanolamida (PEA)
  38. 2007

    Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaTHC:CBD Farmacêutico
  39. 2007

    Selective CB2 up‐regulation in women affected by endometrial inflammation

    InconclusivoMetanáliseInflamaçãoEndometriose
  40. 2007

    Synergy Between Delta9-tetrahydrocannabinol And Morphine In The Arthritic Rat

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+2
  41. 2007

    Testing the Self-Medication Hypothesis of Depression and Aggression in Cannabis-Dependent Subjects

  42. 2007

    The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5 through the CB2 Receptor

  43. 2007

    The effect of extreme marijuana use on the long-term course of bipolar I illness: a single case study.

    FavorávelMetanáliseTranstorno Bipolar
  44. 2007

    The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaTranstornos de Comportamento
  45. 2007

    The endocannabinoid network: insight into the regulation of the neuroendocrine and metabolic systems

  46. 2007

    The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.

    FavorávelEnsaio ClínicoEsclerose MúltiplaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  47. 2007

    The expression of the peripheral cannabinoid receptor on cells of the immune system and non-Hodgkin's lymphomas

    InconclusivoEstudo LaboratorialCâncerCâncer — Linfoma
  48. 2007

    The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo

    FavorávelEstudo em AnimaisEfeitos Adversos da CannabisTetraidrocanabivarina (THCV)
  49. 2007

    The role of alkamides as an active principle of echinacea

    InconclusivoMetanáliseInflamaçãoEquinácea
  50. 2007

    Treatment with lavender aromatherapy in the post-anesthesia care unit reduces opioid requirements of morbidly obese patients undergoing laparoscopic adjustable gastric banding.

    FavorávelEnsaio Clínico Duplo-CegoDorDependência — OpioidesDor — Aguda
  51. 2007

    Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.

  52. 2007

    Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells

    FavorávelEstudo LaboratorialInflamaçãoCOVID-19Canabinoides Sintéticos CP-xVirodamina (O-AEA)
  53. 2006

    A meta-analysis of negative symptoms in dual diagnosis schizophrenia

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+4
  54. 2006

    A Molecular Link Between The Active Component Of Marijuana And Alzheimer's Disease Pathology

    FavorávelEstudo LaboratorialDoença de Alzheimer
  55. 2006

    A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management.

    FavorávelEnsaio ClínicoDorDor — Aguda
  56. 2006

    A Pilot Clinical Study Of Delta9-tetrahydrocannabinol In Patients With Recurrent Glioblastoma Multiforme

    FavorávelEnsaio ClínicoCâncerCâncer — Cérebro
  57. 2006

    Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects

    FavorávelEstudo LaboratorialInflamaçãoAnandamida (AEA)Canabinoides Sintéticos SR-x+1
  58. 2006

    Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

  59. 2006

    Anticonflict effects of lavender oil and identification of its active constituents.

    FavorávelEstudo em AnimaisAnsiedade
  60. 2006

    Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division.

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  61. 2006

    Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

    FavorávelEstudo em AnimaisAnsiedade
  62. 2006

    Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs

  63. 2006

    Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

    FavorávelEstudo LaboratorialTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  64. 2006

    Cannabidiol-induced Apoptosis In Human Leukemia Cells: A Novel Role Of Cannabidiol In The Regulation Of P22phox And Nox4 Expression

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  65. 2006

    Cannabinoid Derivatives Induce Cell Death In Pancreatic MIA PaCa-2 Cells Via A Receptor-independent Mechanism

  66. 2006

    Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.

  67. 2006

    Cannabinoid receptors as a target for therapy of ovarian cancer

    FavorávelEstudo LaboratorialCâncerCâncer — OvárioCanabinoides Sintéticos WIN-x
  68. 2006

    Cannabinoids in acute gastric damage and pancreatitis

  69. 2006

    Cannabinoids Induce Apoptosis Of Pancreatic Tumor Cells Via Endoplasmic Reticulum Stress-related Genes

    FavorávelEstudo LaboratorialCâncerCâncer — PâncreasTetraidrocanabinol (THC)
  70. 2006

    Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.

  71. 2006

    Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.

    FavorávelMetanáliseHepatite
  72. 2006

    Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.

    InconclusivoEstudo LaboratorialDegeneração MacularAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  73. 2006

    Chirality Influences the Effects of Linalool on Physiological Parameters of Stress

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)Hipertensão Arterial
  74. 2006

    Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls

    InconclusivoEnsaio ClínicoAnsiedadeDepressãoDisfunção CognitivaDelta-8-THC
  75. 2006

    Cold exposure stimulates synthesis of the bioactive lipid oleoylethanolamide in rat adipose tissue

  76. 2006

    Comorbidity between substance use disorders and psychiatric conditions

    DesfavorávelMetanáliseDependência QuímicaAnsiedadeDepressão+1
  77. 2006

    Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group

  78. 2006

    Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome.

    FavorávelEnsaio ClínicoTDA e TDAH
  79. 2006

    Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

  80. 2006

    Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production.

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Infarto
  81. 2006

    Delta(9)-tetrahydrocannabinol and the Opioid Receptor Agonist Piritramide Do Not Act Synergistically in Postoperative Pain

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — AgudaTetraidrocanabinol (THC)THC Farmacêutico
  82. 2006

    Delta9-tetrahydrocannabinol-induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaTetraidrocanabinol (THC)
  83. 2006

    Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats

  84. 2006

    Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases

    FavorávelEnsaio ClínicoCâncerNáusea e VômitoCâncer — MelanomaTHC Farmacêutico+3
  85. 2006

    Dronabinol Reduces Signs And Symptoms Of Idiopathic Intracranial Hypertension: A Case Report.

  86. 2006

    Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study.

    FavorávelEnsaio Clínico Duplo-CegoGlaucomaTetraidrocanabinol (THC)
  87. 2006

    Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine

    FavorávelEstudo em AnimaisSíndrome do Choque TóxicoCanabinoides Sintéticos AM-x
  88. 2006

    Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

    InconclusivoEnsaio Clínico Duplo-CegoTraumatismo CranioencefálicoCanabinoide Sintético (não especificado)
  89. 2006

    Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus

    FavorávelEnsaio Clínico Duplo-CegoDiabetesCanabinoide Sintético (não especificado)
  90. 2006

    Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage

    FavorávelEstudo em AnimaisAlterações Cerebrais NeonataisExcitotoxicidadeAnandamida (AEA)
  91. 2006

    Endocannabinoids, feeding and suckling--from our perspective

    InconclusivoMetanáliseGestaçãoAnorexia (perda de apetite)CaquexiaAnandamida (AEA)+1
  92. 2006

    Evaluation of herbal cannabis characteristics by medical users: a randomized trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorDor — Crônica
  93. 2006

    Evolution of the Anticonvulsant Activity of α-Terpineol

    FavorávelEstudo em AnimaisEpilepsia
  94. 2006

    Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

  95. 2006

    Increasing Cannabinoid Levels By Pharmacological And Genetic Manipulation Delay Disease Progression In SOD1 Mice

  96. 2006

    Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo

    DesfavorávelEstudo em AnimaisBronquite
  97. 2006

    Involvement of adenosine A1 and A2A receptors in (-)-linalool-induced antinociception.

    FavorávelEstudo LaboratorialDor
  98. 2006

    Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

    InconclusivoEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  99. 2006

    Marijuana Use And The Risk Of Lung And Upper Aerodigestive Tract Cancers: Results Of A Population-based Case-control Study

    InconclusivoMetanáliseCâncerCâncer — Pulmão
  100. 2006

    Multiple sclerosis may disrupt endocannabinoid brain protection mechanism